Research ExplorerPublicationsTranscatheter aortic and mitral valve interventions: Update ...

Transcatheter aortic and mitral valve interventions: Update 2010

Standard

Transcatheter aortic and mitral valve interventions: Update 2010. / Conradi, Lenard; Treede, Hendrik; Franzen, Olaf; Seiffert, Moritz; Baldus, Stephan; Schirmer, Johannes; Meinertz, Thomas; Reichenspurner, Hermann.

In: Interventional Cardiology, Vol. 2, No. 4, 08.2010, p. 513-523.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Conradi, L, Treede, H, Franzen, O, Seiffert, M, Baldus, S, Schirmer, J, Meinertz, T & Reichenspurner, H 2010, 'Transcatheter aortic and mitral valve interventions: Update 2010', Interventional Cardiology, vol. 2, no. 4, pp. 513-523. https://doi.org/10.2217/ica.10.47

APA

Conradi, L., Treede, H., Franzen, O., Seiffert, M., Baldus, S., Schirmer, J., Meinertz, T., & Reichenspurner, H. (2010). Transcatheter aortic and mitral valve interventions: Update 2010. Interventional Cardiology, 2(4), 513-523. https://doi.org/10.2217/ica.10.47

Vancouver

Conradi L, Treede H, Franzen O, Seiffert M, Baldus S, Schirmer J et al. Transcatheter aortic and mitral valve interventions: Update 2010. Interventional Cardiology. 2010 Aug;2(4):513-523. https://doi.org/10.2217/ica.10.47

Bibtex

@article{a982455b34b648db8cccb95c46f3676b,
title = "Transcatheter aortic and mitral valve interventions: Update 2010",
abstract = "In recent years, the cardiovascular community has witnessed the advent of new, transcatheter-based beating-heart approaches to valvular heart disease. Since the mid-1980s, when balloon valvuloplasty of stenosed aortic valves and percutaneous commissurotomy in mitral stenosis were introduced into clinical practice, interventional valve therapy has seen a tremendous upsurge. Today, transcatheter aortic valve implantation has become a viable treatment alternative for selective cases at specialized centers. While transcatheter aortic valve implantation is currently restricted to high-risk patients and surgical aortic valve replacement remains the reference treatment, broader clinical application can be anticipated for the future. Nonsurgical intervention for treatment of mitral regurgitation is a second field of intense investigation. The growing incidence of congestive heart failure in western societies has created an unmet clinical need for less invasive treatment strategies for patients with functional or organic mitral regurgitation. This article summarizes the current state of transcatheter aortic and mitral valve interventions and discusses future perspectives.",
keywords = "aortic stenosis, aortic valve replacement, mitral regurgitation, mitral valve repair, percutaneous, transcatheter",
author = "Lenard Conradi and Hendrik Treede and Olaf Franzen and Moritz Seiffert and Stephan Baldus and Johannes Schirmer and Thomas Meinertz and Hermann Reichenspurner",
year = "2010",
month = aug,
doi = "10.2217/ica.10.47",
language = "English",
volume = "2",
pages = "513--523",
number = "4",

}

RIS

TY - JOUR

T1 - Transcatheter aortic and mitral valve interventions: Update 2010

AU - Conradi, Lenard

AU - Treede, Hendrik

AU - Franzen, Olaf

AU - Seiffert, Moritz

AU - Baldus, Stephan

AU - Schirmer, Johannes

AU - Meinertz, Thomas

AU - Reichenspurner, Hermann

PY - 2010/8

Y1 - 2010/8

N2 - In recent years, the cardiovascular community has witnessed the advent of new, transcatheter-based beating-heart approaches to valvular heart disease. Since the mid-1980s, when balloon valvuloplasty of stenosed aortic valves and percutaneous commissurotomy in mitral stenosis were introduced into clinical practice, interventional valve therapy has seen a tremendous upsurge. Today, transcatheter aortic valve implantation has become a viable treatment alternative for selective cases at specialized centers. While transcatheter aortic valve implantation is currently restricted to high-risk patients and surgical aortic valve replacement remains the reference treatment, broader clinical application can be anticipated for the future. Nonsurgical intervention for treatment of mitral regurgitation is a second field of intense investigation. The growing incidence of congestive heart failure in western societies has created an unmet clinical need for less invasive treatment strategies for patients with functional or organic mitral regurgitation. This article summarizes the current state of transcatheter aortic and mitral valve interventions and discusses future perspectives.

AB - In recent years, the cardiovascular community has witnessed the advent of new, transcatheter-based beating-heart approaches to valvular heart disease. Since the mid-1980s, when balloon valvuloplasty of stenosed aortic valves and percutaneous commissurotomy in mitral stenosis were introduced into clinical practice, interventional valve therapy has seen a tremendous upsurge. Today, transcatheter aortic valve implantation has become a viable treatment alternative for selective cases at specialized centers. While transcatheter aortic valve implantation is currently restricted to high-risk patients and surgical aortic valve replacement remains the reference treatment, broader clinical application can be anticipated for the future. Nonsurgical intervention for treatment of mitral regurgitation is a second field of intense investigation. The growing incidence of congestive heart failure in western societies has created an unmet clinical need for less invasive treatment strategies for patients with functional or organic mitral regurgitation. This article summarizes the current state of transcatheter aortic and mitral valve interventions and discusses future perspectives.

KW - aortic stenosis

KW - aortic valve replacement

KW - mitral regurgitation

KW - mitral valve repair

KW - percutaneous

KW - transcatheter

UR - http://www.scopus.com/inward/record.url?scp=77956159169&partnerID=8YFLogxK

U2 - 10.2217/ica.10.47

DO - 10.2217/ica.10.47

M3 - SCORING: Review article

AN - SCOPUS:77956159169

VL - 2

SP - 513

EP - 523

IS - 4

ER -